AZTA
Price
$26.05
Change
+$0.69 (+2.72%)
Updated
Jul 13 closing price
Capitalization
1.2B
29 days until earnings call
Intraday BUY SELL Signals
INMD
Price
$15.15
Change
-$0.13 (-0.85%)
Updated
Jul 13 closing price
Capitalization
870.83M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs INMD

AZTA vs INMD Comparison Chart in %
View a ticker or compare two or three
VS
AZTA vs. INMD commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and INMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (AZTA: $26.05 vs. INMD: $15.28)
Brand notoriety: AZTA and INMD are both not notable
AZTA represents the Pharmaceuticals: Other, while INMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: AZTA: 36% vs. INMD: 50%
Market capitalization -- AZTA: $1.2B vs. INMD: $870.83M
AZTA [@Pharmaceuticals: Other] is valued at $1.2B. INMD’s [@Medical/Nursing Services] market capitalization is $870.83M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $160.44B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileINMD’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • INMD’s FA Score: 1 green, 4 red.
According to our system of comparison, INMD is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while INMD’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 5 bearish.
  • INMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INMD is a better buy in the short-term than AZTA.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +1.48% price change this week, while INMD (@Medical/Nursing Services) price change was +3.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was -13.46%.

Reported Earning Dates

AZTA is expected to report earnings on Aug 11, 2026.

INMD is expected to report earnings on Jul 23, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+7.49% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.2B) has a higher market cap than INMD($871M). AZTA has higher P/E ratio than INMD: AZTA (42.43) vs INMD (11.22). INMD YTD gains are higher at: 3.131 vs. AZTA (-21.678). INMD has higher annual earnings (EBITDA): 80.5M vs. AZTA (36.6M). INMD has more cash in the bank: 537M vs. AZTA (381M). INMD has less debt than AZTA: INMD (4.83M) vs AZTA (55.7M). AZTA has higher revenues than INMD: AZTA (596M) vs INMD (375M).
AZTAINMDAZTA / INMD
Capitalization1.2B871M138%
EBITDA36.6M80.5M45%
Gain YTD-21.6783.131-692%
P/E Ratio42.4311.22378%
Revenue596M375M159%
Total Cash381M537M71%
Total Debt55.7M4.83M1,153%
FUNDAMENTALS RATINGS
AZTA vs INMD: Fundamental Ratings
AZTA
INMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9562
PRICE GROWTH RATING
1..100
5646
P/E GROWTH RATING
1..100
8613
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (50) in the Electronic Production Equipment industry is in the same range as INMD (57) in the null industry. This means that AZTA’s stock grew similarly to INMD’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as INMD (100) in the null industry. This means that AZTA’s stock grew similarly to INMD’s over the last 12 months.

INMD's SMR Rating (62) in the null industry is somewhat better than the same rating for AZTA (95) in the Electronic Production Equipment industry. This means that INMD’s stock grew somewhat faster than AZTA’s over the last 12 months.

INMD's Price Growth Rating (46) in the null industry is in the same range as AZTA (56) in the Electronic Production Equipment industry. This means that INMD’s stock grew similarly to AZTA’s over the last 12 months.

INMD's P/E Growth Rating (13) in the null industry is significantly better than the same rating for AZTA (86) in the Electronic Production Equipment industry. This means that INMD’s stock grew significantly faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAINMD
RSI
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
74%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
69%
Advances
ODDS (%)
Bullish Trend 18 days ago
70%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
Bearish Trend 27 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signal:
Gain/Loss:
INMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FISEX36.67N/A
N/A
Franklin Equity Income A
ERLVX30.89N/A
N/A
Eaton Vance Large-Cap Value R6
JOPPX56.75N/A
N/A
Johnson Opportunity
BDAIX34.67-0.35
-1.00%
Baron Durable Advantage Institutional
RICGX67.95-0.75
-1.09%
American Funds Invmt Co of Amer R-6

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with UTMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
-0.85%
UTMD - INMD
47%
Loosely correlated
+3.02%
RVTY - INMD
45%
Loosely correlated
-1.05%
CRL - INMD
45%
Loosely correlated
-1.57%
MTD - INMD
45%
Loosely correlated
+0.26%
AZTA - INMD
45%
Loosely correlated
+2.72%
More